These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21505069)

  • 1. Ex vivo gene therapy for HIV-1 treatment.
    Scherer LJ; Rossi JJ
    Hum Mol Genet; 2011 Apr; 20(R1):R100-7. PubMed ID: 21505069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR5-targeted hematopoietic stem cell gene approaches for HIV disease: current progress and future prospects.
    Lai Y
    Curr Stem Cell Res Ther; 2012 Jul; 7(4):310-7. PubMed ID: 22486585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic-stem-cell-based gene therapy for HIV disease.
    Kiem HP; Jerome KR; Deeks SG; McCune JM
    Cell Stem Cell; 2012 Feb; 10(2):137-47. PubMed ID: 22305563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can gene delivery close the door to HIV-1 entry after escape?
    Swan CH; Torbett BE
    J Med Primatol; 2006 Aug; 35(4-5):236-47. PubMed ID: 16872287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic stem cell transplantation for HIV cure.
    Kuritzkes DR
    J Clin Invest; 2016 Feb; 126(2):432-7. PubMed ID: 26731468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5.
    Maier DA; Brennan AL; Jiang S; Binder-Scholl GK; Lee G; Plesa G; Zheng Z; Cotte J; Carpenito C; Wood T; Spratt SK; Ando D; Gregory P; Holmes MC; Perez EE; Riley JL; Carroll RG; June CH; Levine BL
    Hum Gene Ther; 2013 Mar; 24(3):245-58. PubMed ID: 23360514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrabodies as antiviral agents.
    Marasco WA
    Curr Top Microbiol Immunol; 2001; 260():247-70. PubMed ID: 11443877
    [No Abstract]   [Full Text] [Related]  

  • 8. CCR5Δ32 mutation and HIV infection: basis for curative HIV therapy.
    Allers K; Schneider T
    Curr Opin Virol; 2015 Oct; 14():24-9. PubMed ID: 26143158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector.
    Walker JE; Chen RX; McGee J; Nacey C; Pollard RB; Abedi M; Bauer G; Nolta JA; Anderson JS
    J Virol; 2012 May; 86(10):5719-29. PubMed ID: 22398281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report.
    Duarte RF; Salgado M; Sánchez-Ortega I; Arnan M; Canals C; Domingo-Domenech E; Fernández-de-Sevilla A; González-Barca E; Morón-López S; Nogues N; Patiño B; Puertas MC; Clotet B; Petz LD; Querol S; Martinez-Picado J
    Lancet HIV; 2015 Jun; 2(6):e236-42. PubMed ID: 26423196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 CCR5 gene therapy will fail unless it is combined with a suicide gene.
    Pandit A; de Boer RJ
    Sci Rep; 2015 Dec; 5():18088. PubMed ID: 26674113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.
    Bai J; Rossi J; Akkina R
    AIDS Res Hum Retroviruses; 2001 Mar; 17(5):385-99. PubMed ID: 11282007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy.
    Anderson JS; Javien J; Nolta JA; Bauer G
    Mol Ther; 2009 Dec; 17(12):2103-14. PubMed ID: 19690520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-Delivered Entry Inhibitors for HIV-1: CCR5 Downregulation and Blocking Virus/Membrane Fusion in Defending the Host Cell Population.
    Symonds G; Bartlett JS; Kiem HP; Tsie M; Breton L
    AIDS Patient Care STDS; 2016 Dec; 30(12):545-550. PubMed ID: 27905841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in CCR5 regulation for HIV cure.
    Garg K; Khan AR; Taneja P
    Adv Protein Chem Struct Biol; 2021; 126():123-149. PubMed ID: 34090613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Therapy to Cure HIV: Where to from Here?
    Johnston R
    AIDS Patient Care STDS; 2016 Dec; 30(12):531-533. PubMed ID: 27905839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice.
    Ringpis GE; Shimizu S; Arokium H; Camba-Colón J; Carroll MV; Cortado R; Xie Y; Kim PY; Sahakyan A; Lowe EL; Narukawa M; Kandarian FN; Burke BP; Symonds GP; An DS; Chen IS; Kamata M
    PLoS One; 2012; 7(12):e53492. PubMed ID: 23300932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.
    Hütter G; Nowak D; Mossner M; Ganepola S; Müssig A; Allers K; Schneider T; Hofmann J; Kücherer C; Blau O; Blau IW; Hofmann WK; Thiel E
    N Engl J Med; 2009 Feb; 360(7):692-8. PubMed ID: 19213682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs.
    Li MJ; Bauer G; Michienzi A; Yee JK; Lee NS; Kim J; Li S; Castanotto D; Zaia J; Rossi JJ
    Mol Ther; 2003 Aug; 8(2):196-206. PubMed ID: 12907142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Applications of Genome Editing to HIV Cure.
    Wang CX; Cannon PM
    AIDS Patient Care STDS; 2016 Dec; 30(12):539-544. PubMed ID: 27854119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.